Abstract Innovative financing mobilizes funds across varied channels using solidarity, Public-Private Partnerships and catalytic mechanisms to address unmet global health needs and engage investors as partners in development. As a supplementary measure to official development assistances (ODA), it offers a potential remedy for the current challenges in global health financing. Its significance has been magnified in the post-COVID era, where inadequate funding presents a significant hurdle to achieving Universal Health Coverage by 2030. Although efforts to promote innovative financing mechanisms have yielded some impactful results, existing bottlenecks hinder their widespread adoption and implementation. Collaboration among stakeholders is now imperative to foster the development and adoption of innovative financing tools in global health, necessitating the upgrading of existing methods and exploration of new avenues. We strongly advocate for engagement with the private sector, as it could revitalize investments in global health through the infusion of additional financial resources. The significance of innovation and the transformation of global health financing mechanisms also warrant attention. It is high time for all stakeholders to join forces and take actions.
Wang et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: